SFG
PFE icon

StrategIQ Financial Group’s Pfizer PFE Stock Holding History

StrategIQ Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$371K Sell
12,881
-3,609
-22% -$109K 0.04% 240
2023
Q3 		$547K Sell
16,490
-581
-3% -$20.5K 0.06% 201
2023
Q2 		$626K Sell
17,071
-100
-0.6% -$3.89K 0.07% 188
2023
Q1 		$701K Sell
17,171
-168
-1% -$7.26K 0.08% 160
2022
Q4 		$888K Buy
17,339
+10
+0.1% +$479 0.1% 137
2022
Q3 		$758K Buy
17,329
+1,405
+9% +$68.3K 0.1% 141
2022
Q2 		$835K Hold
15,924
– – 0.1% 139
2022
Q1 		$824K Sell
15,924
-1,097
-6% -$56.9K 0.09% 155
2021
Q4 		$1M Buy
17,021
+10,180
+149% +$504K 0.1% 138
2021
Q3 		$294K Buy
6,841
+192
+3% +$8.51K 0.06% 177
2021
Q2 		$260K Buy
6,649
+9
+0.1% +$350 0.05% 188
2021
Q1 		$241K Buy
6,640
+30
+0.5% +$1.06K 0.05% 192
2020
Q4 		$243K Buy
6,610
+346
+6% +$12.7K 0.05% 180
2020
Q3 		$218K Buy
+6,264
New +$220K 0.05% 180
2020
Q2 		– Sell
-6,487
Closed -$201K – 192
2020
Q1 		$201K Sell
6,487
-64
-1% -$2.18K 0.06% 175
2019
Q4 		$243K Buy
6,551
+181
+3% +$6.45K 0.06% 184
2019
Q3 		$217K Sell
6,370
-460
-7% -$16.7K 0.06% 182
2019
Q2 		$281K Buy
6,830
+472
+7% +$18.7K 0.08% 162
2019
Q1 		$257K Buy
6,358
+11
+0.2% +$441 0.08% 164
2018
Q4 		$263K Sell
6,347
-518
-8% -$21.5K 0.09% 153
2018
Q3 		$287K Buy
6,865
+525
+8% +$20.2K 0.09% 153
2018
Q2 		$218K Buy
+6,340
New +$217K 0.08% 166

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

StrategIQ Financial Group's PFE Position: Q4 2023 in Review

StrategIQ Financial Group reduced its Pfizer (PFE) stake by 22% in Q4 2023, selling an estimated $109K and leaving 12,881 shares worth $371K. The position accounts for 0.04% of the portfolio, ranked #240.

StrategIQ Financial Group first reported a position in PFE in Q2 2018 and has held it in 22 quarters since. The position peaked at $1M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • StrategIQ Financial Group held 12,881 shares of Pfizer worth $371K as of Q4 2023.
  • StrategIQ Financial Group sold 3,609 Pfizer shares in Q4 2023, an estimated $109K.
  • Pfizer made up 0.04% of StrategIQ Financial Group's portfolio in Q4 2023, its #240 holding.
  • StrategIQ Financial Group first reported a position in Pfizer in Q2 2018 and has held it in 22 quarters since.
  • StrategIQ Financial Group's Pfizer position peaked at $1M in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.